SOX2 and adenocarcinoma: In non-small cell lung cancer (NSCLC), the amplification and subsequent overexpression of the SOX2 gene were common in both squamous cell carcinomas and adenocarcinomas (with higher expressions in squamous cell carcinomas compared to adenocarcinomas) [42,57,58].